Knowledge of factors associated with medication adherence could help HIV clinicians to target
persons in need of intervention, design these interventions, and help researchers to plan …

Background Before April 2022, monkeypox virus infection in humans was seldom reported
outside African regions where it is endemic. Currently, cases are occurring worldwide. …

Affective disorders have been reported as the most common mental health problem in
persons with HIV infection. Depression has a significant impact on the quality of life of persons …

The HIV-1 integrase, responsible for the chromosomal integration of the newly synthesized
doublestranded viral DNA into the host genomic DNA, represents a new and important target …

In 1991, the AIDS Task Force of the American Academy of Neurology published nomenclature
and research case definitions to guide the diagnosis of neurologic manifestations of HIV-1 …

Since May 2022, an outbreak of monkeypox has been ongoing in non-endemic countries. We
report four cases in Italy in young adult men reporting condomless sexual intercourse. The …

Objectives: To identify variables predictive of nonadherence to highly active antiretroviral
therapy (HAART) and to assess whether self-reported symptoms or medication side effects are …

Background Dolutegravir has been shown to be non-inferior to an integrase inhibitor and
superior to a non-nucleoside reverse transcriptase inhibitor (NNRTI). In FLAMINGO, we …

Background Effective two-drug regimens could decrease long-term drug exposure and toxicity
with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and …

SARS-CoV-2 is associated with a 3.4% mortality rate in patients with severe disease. The
pathogenesis of severe cases remains unknown. We performed an in-depth prospective …